{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:10:58Z","timestamp":1791493858652,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":504,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["R21TR003941"],"award-info":[{"award-number":["R21TR003941"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"United Leukodystrophy Foundation"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s13311-022-01226-7","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T12:02:49Z","timestamp":1649073769000},"page":"1007-1017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Nervonic Acid Attenuates Accumulation of Very Long-Chain Fatty Acids and is a Potential Therapy for Adrenoleukodystrophy"],"prefix":"10.1016","volume":"19","author":[{"given":"Marcia R.","family":"Terluk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne","family":"Tieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhee A.","family":"Sahasrabudhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald V.","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1692-1539","authenticated-orcid":false,"given":"Reena V.","family":"Kartha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-022-01226-7_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.biochi.2013.11.023","article-title":"Pathophysiology of X-linked adrenoleukodystrophy","volume":"98","author":"Berger","year":"2014","journal-title":"Biochimie"},{"issue":"10","key":"10.1007\/s13311-022-01226-7_bib2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrendo.2016.90","article-title":"Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history","volume":"12","author":"Kemp","year":"2016","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1007\/s13311-022-01226-7_bib3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1128\/MCB.23.2.744-753.2003","article-title":"Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy","volume":"23","author":"McGuinness","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1007\/s13311-022-01226-7_bib4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ymgme.2004.09.015","article-title":"Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy","volume":"84","author":"Kemp","year":"2005","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1007\/s13311-022-01226-7_bib5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/emmm.201000061","article-title":"The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy","volume":"2","author":"Ofman","year":"2010","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1007\/s13311-022-01226-7_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jdn.10003","article-title":"X-linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies","volume":"80","author":"Turk","year":"2020","journal-title":"Int J Dev Neurosci"},{"issue":"Pt 12","key":"10.1007\/s13311-022-01226-7_bib7","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1093\/brain\/aws292","article-title":"Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy","volume":"135","author":"L\u00f3pez-Erauskin","year":"2012","journal-title":"Brain"},{"issue":"4","key":"10.1007\/s13311-022-01226-7_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/ijns2040015","article-title":"Newborn Screening for X-Linked Adrenoleukodystrophy","volume":"2","author":"Moser","year":"2016","journal-title":"Int J Neonatal Screen"},{"issue":"2","key":"10.1007\/s13311-022-01226-7_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.nurx.2006.01.004","article-title":"Therapy of X-linked adrenoleukodystrophy","volume":"3","author":"Moser","year":"2006","journal-title":"NeuroRx"},{"issue":"17","key":"10.1007\/s13311-022-01226-7_bib10","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","article-title":"Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy","volume":"377","author":"Eichler","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1007\/s13311-022-01226-7_bib11","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archneur.62.7.1073","article-title":"Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil","volume":"62","author":"Moser","year":"2005","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1007\/s13311-022-01226-7_bib12","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/bcp.12897","article-title":"A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophy","volume":"81","author":"Ahmed","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1007\/s13311-022-01226-7_bib13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199309093291101","article-title":"A two-year trial of oleic and erucic acids (\"Lorenzo's oil\") as treatment for adrenomyeloneuropathy","volume":"329","author":"Aubourg","year":"1993","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1007\/s13311-022-01226-7_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/BF02536120","article-title":"Effects of dietary saturated fat on erucic acid induced myocardial lipidosis in rats","volume":"27","author":"Kramer","year":"1992","journal-title":"Lipids"},{"issue":"4","key":"10.1007\/s13311-022-01226-7_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0306-9877(94)90122-8","article-title":"Nervonic acid and demyelinating disease","volume":"42","author":"Sargent","year":"1994","journal-title":"Med Hypotheses"},{"key":"10.1007\/s13311-022-01226-7_bib16","doi-asserted-by":"crossref","unstructured":"Lewkowicz N, Pi\u0105tek P, Namieci\u0144ska M, Domowicz M, Bonikowski R, Szemraj J, et al. Naturally Occurring Nervonic Acid Ester Improves Myelin Synthesis by Human Oligodendrocytes. Cells. 2019;8(8).","DOI":"10.3390\/cells8080786"},{"issue":"1","key":"10.1007\/s13311-022-01226-7_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/oxfordjournals.jbchem.a124284","article-title":"Glucosylceramide and glucosylsphingosine metabolism in cultured fibroblasts deficient in acid beta-glucosidase activity","volume":"115","author":"Sasagasako","year":"1994","journal-title":"J Biochem"},{"issue":"1","key":"10.1007\/s13311-022-01226-7_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/mgme.2001.3170","article-title":"Quantitative determination of plasma c8\u2013c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders","volume":"73","author":"Lagerstedt","year":"2001","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1007\/s13311-022-01226-7_bib19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ymgme.2009.03.010","article-title":"Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS\/MS) method","volume":"97","author":"Hubbard","year":"2009","journal-title":"Mol Genet Metab"},{"issue":"8","key":"10.1007\/s13311-022-01226-7_bib20","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1194\/jlr.D800051-JLR200","article-title":"Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers","volume":"50","author":"Shaner","year":"2009","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1007\/s13311-022-01226-7_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11745-014-3975-7","article-title":"The phospholipidomic signatures of human blood microparticles, platelets and platelet-derived microparticles: a comparative HILIC-ESI-MS investigation","volume":"50","author":"Losito","year":"2015","journal-title":"Lipids"},{"key":"10.1007\/s13311-022-01226-7_bib22","unstructured":"Core Team R. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria 2021."},{"key":"10.1007\/s13311-022-01226-7_bib23","doi-asserted-by":"crossref","unstructured":"Poustie VJ, Wildgoose J. Dietary interventions for phenylketonuria. Cochrane Database Syst Rev. 2010(1):CD001304.","DOI":"10.1002\/14651858.CD001304.pub2"},{"issue":"4","key":"10.1007\/s13311-022-01226-7_bib24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s10545-009-1126-8","article-title":"Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop","volume":"32","author":"Spiekerkoetter","year":"2009","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"10.1007\/s13311-022-01226-7_bib25","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s10545-007-0718-4","article-title":"Nutritional management of patients with urea cycle disorders","volume":"30","author":"Singh","year":"2007","journal-title":"J Inherit Metab Dis"},{"issue":"7","key":"10.1007\/s13311-022-01226-7_bib26","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/ajmg.a.61171","article-title":"A report on state-wide implementation of newborn screening for X-linked Adrenoleukodystrophy","volume":"179","author":"Wiens","year":"2019","journal-title":"Am J Med Genet A"},{"issue":"12","key":"10.1007\/s13311-022-01226-7_bib27","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/hmg\/ddn085","article-title":"Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy","volume":"17","author":"Fourcade","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1007\/s13311-022-01226-7_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1007\/s13311-022-01226-7_bib29","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1046\/j.1471-4159.1998.71062528.x","article-title":"Fatty acid composition of human brain phospholipids during normal development","volume":"71","author":"Mart\u00ednez","year":"1998","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-022-01226-7_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.plefa.2016.01.002","article-title":"Long-chain saturated and monounsaturated fatty acids associate with development of premature infants up to 18 months of age","volume":"107","author":"Strandvik","year":"2016","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1007\/s13311-022-01226-7_bib31","doi-asserted-by":"crossref","unstructured":"Li Q, Chen J, Yu X, Gao JM. A mini review of nervonic acid: Source, production, and biological functions. Food Chem. 2019;301:125286.","DOI":"10.1016\/j.foodchem.2019.125286"},{"key":"10.1007\/s13311-022-01226-7_bib32","doi-asserted-by":"crossref","unstructured":"Yu J, Yuan T, Zhang X, Jin Q, Wei W, Wang X. Quantification of Nervonic Acid in Human Milk in the First 30 Days of Lactation: Influence of Lactation Stages and Comparison with Infant Formulae. Nutrients. 2019;11(8).","DOI":"10.3390\/nu11081892"},{"issue":"3","key":"10.1007\/s13311-022-01226-7_bib33","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1194\/jlr.M044586","article-title":"Lorenzo's oil inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated very long-chain fatty acid","volume":"55","author":"Sassa","year":"2014","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1007\/s13311-022-01226-7_bib34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1212\/WNL.36.3.357","article-title":"Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22\u201326 fatty acids","volume":"36","author":"Rizzo","year":"1986","journal-title":"Neurology"},{"issue":"11","key":"10.1007\/s13311-022-01226-7_bib35","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0022-2275(20)32471-8","article-title":"Localization of nervonic acid beta-oxidation in human and rodent peroxisomes: impaired oxidation in Zellweger syndrome and X-linked adrenoleukodystrophy","volume":"39","author":"Sandhir","year":"1998","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1007\/s13311-022-01226-7_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12944-018-0710-z","article-title":"Palmitoleic acid (16:1n7) increases oxygen consumption, fatty acid oxidation and ATP content in white adipocytes","volume":"17","author":"Cruz","year":"2018","journal-title":"Lipids Health Dis"},{"issue":"2","key":"10.1007\/s13311-022-01226-7_bib37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1677\/JOE-07-0082","article-title":"Mechanisms involved in the cytotoxic and cytoprotective actions of saturated versus monounsaturated long-chain fatty acids in pancreatic beta-cells","volume":"194","author":"Diakogiannaki","year":"2007","journal-title":"J Endocrinol"},{"issue":"10","key":"10.1007\/s13311-022-01226-7_bib38","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s11745-998-0297-4","article-title":"Effects of feeding Lunaria oil rich in nervonic and erucic acids on the fatty acid compositions of sphingomyelins from erythrocytes, liver, and brain of the quaking mouse mutant","volume":"33","author":"Cook","year":"1998","journal-title":"Lipids"},{"issue":"4","key":"10.1007\/s13311-022-01226-7_bib39","first-page":"A579","article-title":"Nervonic acid improves learning memory ability in normal mice and mice with experimental memory impairment","volume":"18","author":"Li","year":"2004","journal-title":"FASEB J"},{"issue":"1","key":"10.1007\/s13311-022-01226-7_bib40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1515\/tnsci-2020-0171","article-title":"Nervonic acid amends motor disorder in a mouse model of Parkinson's disease","volume":"12","author":"Hu","year":"2021","journal-title":"Transl Neurosci"},{"issue":"1","key":"10.1007\/s13311-022-01226-7_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5650\/jos.ess20262","article-title":"Protective Effect of Nervonic Acid Against 6-Hydroxydopamine-Induced Oxidative Stress in PC-12 Cells","volume":"70","author":"Umemoto","year":"2021","journal-title":"J Oleo Sci"},{"key":"10.1007\/s13311-022-01226-7_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8617143","article-title":"Effects of Malania oleifera Chun Oil on the Improvement of Learning and Memory Function in Mice","volume":"2020","author":"Wu","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"issue":"11","key":"10.1007\/s13311-022-01226-7_bib43","doi-asserted-by":"crossref","first-page":"15314","DOI":"10.1096\/fj.202000525R","article-title":"Nervonic acid limits weight gain in a mouse model of diet-induced obesity","volume":"34","author":"Keppley","year":"2020","journal-title":"FASEB J"},{"key":"10.1007\/s13311-022-01226-7_bib44","doi-asserted-by":"crossref","unstructured":"Delgado GE, Kramer BK, Lorkowski S, Marz W, von Schacky C, Kleber ME. Individual omega-9 monounsaturated fatty acids and mortality-The Ludwigshafen Risk and Cardiovascular Health Study. J Clin Lipidol. 2017;11(1):126\u201335 e5.","DOI":"10.1016\/j.jacl.2016.10.015"},{"key":"10.1007\/s13311-022-01226-7_bib45","doi-asserted-by":"crossref","unstructured":"Imamura F, Lemaitre RN, King IB, Song X, Steffen LM, Folsom AR, et al. Long-chain monounsaturated Fatty acids and incidence of congestive heart failure in 2 prospective cohorts. Circulation. 2013;127(14):1512\u201321, 21e1\u201318.","DOI":"10.1161\/CIRCULATIONAHA.112.001197"},{"issue":"6","key":"10.1007\/s13311-022-01226-7_bib46","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1536\/ihj.46.975","article-title":"Relationships between serum unsaturated fatty acids and coronary risk factors: negative relations between nervonic acid and obesity-related risk factors","volume":"46","author":"Oda","year":"2005","journal-title":"Int Heart J"},{"issue":"3","key":"10.1007\/s13311-022-01226-7_bib47","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/jnnp.67.3.290","article-title":"Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with \"Lorenzo's oil\"","volume":"67","author":"van Geel","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-022-01226-7_bib48","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev.nu.15.070195.002115","article-title":"Dietary management of X-linked adrenoleukodystrophy","volume":"15","author":"Moser","year":"1995","journal-title":"Annu Rev Nutr"},{"issue":"4","key":"10.1007\/s13311-022-01226-7_bib49","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1471-4159.1976.tb04461.x-i1","article-title":"Fatty acid abnormality in adrenoleukodystrophy","volume":"26","author":"Igarashi","year":"1976","journal-title":"J Neurochem"},{"issue":"4","key":"10.1007\/s13311-022-01226-7_bib50","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1750-3639.2010.00391.x","article-title":"Biochemical aspects of X-linked adrenoleukodystrophy","volume":"20","author":"Kemp","year":"2010","journal-title":"Brain Pathol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01226-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-022-01226-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923011194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923011194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01226-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:56:33Z","timestamp":1761807393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923011194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1878747923011194"],"URL":"https:\/\/doi.org\/10.1007\/s13311-022-01226-7","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nervonic Acid Attenuates Accumulation of Very Long-Chain Fatty Acids and is a Potential Therapy for Adrenoleukodystrophy","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-022-01226-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}